COMP <GO>
NTLA vs ORKA // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Intellia Therapeutics Inc. (NASDAQ) VS. Oruka Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: NTLA 1
— ORKA 7
■ METRIC PARITY
LAST: $11.66 (-6.50%) • MKT CAP: $1.75B
options-implied-move
—
LAST: $95.43 (-1.49%) • MKT CAP: $6.41B
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NTLA VS. ORKA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NTLA | ORKA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -18.80% | -16.20 | ORKA | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -21.35% | -1.38% | -19.97 | ORKA | /fcf-yield <GO> |
| Operating Margin | -60.00% | -6.80% | -53.20 | ORKA | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -5.90% | -54.10 | ORKA | /net-margins <GO> |
| Revenue Growth (YoY) | 16.90% | -4.40% | +21.30 | NTLA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.17 | 26.00 | -24.83 | ORKA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 4/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 52.2 | 67.0 | -14.80 | ORKA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.13 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 28.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.75B | $6.41B | -$4.67B | ORKA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NTLA REV | ORKA REV | NTLA GROSS % | ORKA GROSS % | NTLA FCF | ORKA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $67.7M | $341.7M | — | — | -$395.9M | -$88.4M |
| FY 2024 | $57.9M | $246.7M | — | — | -$354.7M | -$58.0M |
| FY 2023 | $36.3M | $20.4M | — | — | -$394.1M | -$5.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NTLA // BETA —
ORKA // BETA 1.13